IONIS PHARMACEUTICALS INC - IONS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | — | P | A | 5,000.0 | 29.64 | 148,200.0 | 27,000.0 | View | |
| Oct 19, 2026 | EVP, Chief Human Resources Ofc | M | D | 2,820.0 | 0.0 | 0.0 | 49,884.0 | View | |
| Oct 19, 2026 | EVP, Chief Human Resources Ofc | S | D | 1,357.0 | 43.5386 | 59,081.88 | 17,811.0 | View | |
| Oct 19, 2026 | EVP, Chief Human Resources Ofc | M | A | 2,820.0 | 0.0 | 0.0 | 19,168.0 | View | |
| Oct 19, 2026 | EVP Research | M | D | 125.0 | 0.0 | 0.0 | 486.0 | View | |
| Oct 19, 2026 | EVP Research | S | D | 53.0 | 43.5389 | 2,307.56 | 390.0 | View | |
| Oct 19, 2026 | EVP Research | M | A | 125.0 | 0.0 | 0.0 | 443.0 | View | |
| Sep 02, 2026 | EVP, Chief Scientific Officer | J | A | 110.0 | 51.306 | 5,643.66 | 60,128.0 | View | |
| Sep 02, 2026 | EVP CLO & General Counsel | J | A | 63.0 | 51.306 | 3,232.28 | 59,205.0 | View | |
| Sep 02, 2026 | Chief Executive Officer | J | A | 98.0 | 51.306 | 5,027.99 | 242,760.0 | View | |
| Sep 02, 2026 | EVP, Corp and Development Ops | J | A | 58.0 | 51.306 | 2,975.75 | 102,883.0 | View | |
| Jul 31, 2026 | — | P | A | 5,000.0 | 51.6 | 258,000.0 | 24,000.0 | View | |
| Jul 31, 2026 | — | P | A | 15,000.0 | 53.38 | 800,700.0 | 19,000.0 | View | |
| Jul 17, 2026 | — | A | A | 3,399.0 | 0.0 | 0.0 | 3,399.0 | View | |
| Jul 17, 2026 | — | A | A | 3,399.0 | 0.0 | 0.0 | 3,399.0 | View | |
| Jul 17, 2026 | — | M | D | 5,220.0 | 0.0 | 0.0 | 2,301.0 | View | |
| Jul 17, 2026 | — | M | A | 5,220.0 | 0.0 | 0.0 | 51,306.0 | View | |
| Jul 17, 2026 | — | M | D | 5,220.0 | 0.0 | 0.0 | 2,301.0 | View | |
| Jul 17, 2026 | — | M | A | 5,220.0 | 0.0 | 0.0 | 161,233.0 | View | |
| Jul 09, 2026 | EVP, Chief Scientific Officer | J | D | 15,000.0 | 0.0 | 0.0 | 12,109.0 | View | |
| Jul 09, 2026 | EVP, Chief Scientific Officer | S | D | 15,000.0 | 85.462 | 1,281,930.0 | 0.0 | View | |
| Jul 09, 2026 | EVP, Chief Scientific Officer | J | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jul 09, 2026 | EVP, Chief Scientific Officer | S | D | 5,536.0 | 83.579 | 462,693.34 | 75,018.0 | View | |
| Jul 09, 2026 | — | M | D | 10,111.0 | 0.0 | 0.0 | 0.0 | View | |
| Jul 09, 2026 | — | S | D | 10,111.0 | 85.4156 | 863,637.13 | 3,811.0 | View | |
| Jul 09, 2026 | — | M | A | 10,111.0 | 47.11 | 476,329.21 | 13,922.0 | View | |
| Jul 09, 2026 | EVP, Chief Development Officer | S | D | 362.0 | 84.3 | 30,516.6 | 22,096.0 | View | |
| Jul 06, 2026 | — | A | A | 2,301.0 | 0.0 | 0.0 | 9,451.0 | View | |
| Jul 06, 2026 | — | A | A | 5,369.0 | 0.0 | 0.0 | 5,369.0 | View | |
| Jul 06, 2026 | — | A | A | 2,301.0 | 0.0 | 0.0 | 7,521.0 | View | |
| Jul 06, 2026 | — | A | A | 5,369.0 | 0.0 | 0.0 | 5,369.0 | View | |
| Jul 06, 2026 | — | A | A | 2,301.0 | 0.0 | 0.0 | 7,521.0 | View | |
| Jul 06, 2026 | — | A | A | 5,369.0 | 0.0 | 0.0 | 5,369.0 | View | |
| Jul 06, 2026 | — | A | A | 2,301.0 | 0.0 | 0.0 | 16,277.0 | View | |
| Jul 06, 2026 | — | A | A | 5,369.0 | 0.0 | 0.0 | 5,369.0 | View | |
| Jul 06, 2026 | — | M | D | 11,518.0 | 0.0 | 0.0 | 0.0 | View | |
| Jul 06, 2026 | — | S | D | 11,419.0 | 79.0394 | 902,550.91 | 11,014.0 | View | |
| Jul 06, 2026 | — | S | D | 99.0 | 79.45 | 7,865.55 | 22,433.0 | View | |
| Jul 06, 2026 | — | M | A | 11,518.0 | 39.94 | 460,028.92 | 22,532.0 | View | |
| Jul 06, 2026 | — | A | A | 2,301.0 | 0.0 | 0.0 | 12,198.0 | View | |
| Jul 06, 2026 | — | A | A | 5,369.0 | 0.0 | 0.0 | 5,369.0 | View | |
| Jul 06, 2026 | — | A | A | 2,301.0 | 0.0 | 0.0 | 7,521.0 | View | |
| Jul 06, 2026 | — | A | A | 5,369.0 | 0.0 | 0.0 | 5,369.0 | View | |
| Jul 06, 2026 | — | A | A | 2,301.0 | 0.0 | 0.0 | 7,521.0 | View | |
| Jul 06, 2026 | — | A | A | 5,369.0 | 0.0 | 0.0 | 5,369.0 | View | |
| Jun 30, 2026 | EVP, Chief Business Officer | M | D | 3,866.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 30, 2026 | EVP, Chief Business Officer | M | D | 1,769.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 30, 2026 | EVP, Chief Business Officer | S | D | 5,635.0 | 80.1595 | 451,698.78 | 4,669.0 | View | |
| Jun 30, 2026 | EVP, Chief Business Officer | M | A | 1,769.0 | 32.6 | 57,669.4 | 10,304.0 | View | |
| Jun 30, 2026 | EVP, Chief Business Officer | M | A | 3,866.0 | 56.78 | 219,511.48 | 8,535.0 | View | |
| Jun 30, 2026 | EVP CLO & General Counsel | S | D | 3,069.0 | 80.0 | 245,520.0 | 61,470.0 | View | |
| Jun 30, 2026 | EVP, Chf Clinical Develop Ofcr | M | D | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 30, 2026 | EVP, Chf Clinical Develop Ofcr | S | D | 26,000.0 | 81.046 | 2,107,196.0 | 77,114.0 | View | |
| Jun 30, 2026 | EVP, Chf Clinical Develop Ofcr | M | A | 26,000.0 | 60.89 | 1,583,140.0 | 103,114.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | M | D | 50,000.0 | 0.0 | 0.0 | 99,872.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | M | D | 21,072.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | M | D | 14,565.0 | 0.0 | 0.0 | 21,072.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | S | D | 50,000.0 | 80.59 | 4,029,500.0 | 245,571.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | M | A | 50,000.0 | 56.78 | 2,839,000.0 | 295,571.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | S | D | 21,072.0 | 78.49 | 1,653,941.28 | 245,571.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | M | A | 21,072.0 | 32.6 | 686,947.2 | 266,643.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | S | D | 14,565.0 | 78.4128 | 1,142,082.43 | 245,571.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | M | A | 14,565.0 | 32.6 | 474,819.0 | 260,136.0 | View | |
| Jun 26, 2026 | EVP Research | S | D | 10,602.0 | 79.1824 | 839,491.8 | 21,759.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | D | 21,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | D | 7,951.0 | 0.0 | 0.0 | 21,000.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | D | 19,895.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | D | 12,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | S | D | 19,842.0 | 74.0503 | 1,469,306.05 | 22,458.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | S | D | 41,004.0 | 73.0934 | 2,997,121.77 | 42,300.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | A | 19,895.0 | 56.78 | 1,129,638.1 | 83,304.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | A | 12,000.0 | 32.6 | 391,200.0 | 63,409.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | A | 21,000.0 | 60.89 | 1,278,690.0 | 51,409.0 | View | |
| Jun 16, 2026 | EVP, Chief Development Officer | M | A | 7,951.0 | 60.89 | 484,136.39 | 30,409.0 | View | |
| Jun 16, 2026 | — | M | D | 8,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 16, 2026 | — | S | D | 8,000.0 | 73.49 | 587,920.0 | 156,013.0 | View | |
| Jun 16, 2026 | — | M | A | 8,000.0 | 24.42 | 195,360.0 | 164,013.0 | View | |
| Jun 08, 2026 | — | A | A | 10,753.0 | 0.0 | 0.0 | 10,753.0 | View | |
| Jun 08, 2026 | — | A | A | 10,753.0 | 0.0 | 0.0 | 10,753.0 | View | |
| Jun 03, 2026 | — | M | D | 8,000.0 | 0.0 | 0.0 | 8,000.0 | View | |
| Jun 03, 2026 | — | S | D | 8,000.0 | 75.67 | 605,360.0 | 156,013.0 | View | |
| Jun 03, 2026 | — | M | A | 8,000.0 | 24.42 | 195,360.0 | 164,013.0 | View |